OMTHERA PHARMACEUTICALS INC

Inactive Instrument

News Omthera Pharmaceuticals Inc

Equities

US68217A1034

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE
2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	13-09-20	PU
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	13-07-16	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	13-07-09	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	13-06-27	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13-06-13	PR
Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	13-06-10	RE
Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	13-06-10	RE
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm	13-05-30	PR
GlaxoSmithKline plc : GSK bets on chimp virus with $321 million vaccines buy	13-05-29	RE
Omthera Pharmaceuticals Inc : Law Firm Brower Piven Announces Investigation of Omthera Pharmaceuticals, Inc. Proposed Buyout	13-05-29	BU
Omthera Pharmaceuticals Inc : Ryan & Maniskas, LLP Announces Investigation of Omthera Pharmaceuticals, Inc.	13-05-29	PR
Omthera Pharmaceuticals Inc : OMTHERA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Omthera Pharmaceuticals, Inc. Following Announcement of Proposed Sale of Company to AstraZeneca	13-05-28	BU
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	13-05-28	RE
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	13-05-28	RE
Omthera Pharmaceuticals Inc : AstraZeneca to Acquire Omthera Pharmaceuticals Including NDA-Ready Novel Dyslipidemia Treatment to Complement Cardiovascular Portfolio	13-05-28	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering	13-04-16	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
Stock
News Omthera Pharmaceuticals Inc

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer